Nov 15 (Reuters) - Graphite Bio Inc GRPH.O :
* LENZ THERAPEUTICS AND GRAPHITE BIO ANNOUNCE MERGER
AGREEMENT
* GRAPHITE BIO INC - COMBINED COMPANY EXPECTED TO HAVE
APPROXIMATELY $225 MILLION OF CASH OR CASH EQUIVALENTS AT CLOSE
* GRAPHITE BIO INC - GRAPHITE BIO IS EXPECTED TO CONTRIBUTE
$115
MILLION TO COMBINED ENTITY
* GRAPHITE BIO INC - GRAPHITE BIO EXPECTS TO PAY A DIVIDEND
TO
GRAPHITE BIO SHAREHOLDERS OF APPROXIMATELY $60 MILLION AT CLOSE
OF TRANSACTION
* GRAPHITE BIO INC - COMBINED COMPANY IS EXPECTED TO TRADE
ON
NASDAQ UNDER TICKER SYMBOL "LENZ."
Source text for Eikon: ID:nBwwCNPta
Further company coverage: GRPH.O
((Reuters.Briefs@thomsonreuters.com))